Inspirna is a clinical stage biopharmaceutical company developing first-in-class cancer therapeutics using its proprietary RNA-DRIVEr™ platform to target previously untreatable common cancers with small molecules and biologics
Inspirna is a clinical stage biopharmaceutical company developing first-in-class cancer therapeutics using its proprietary RNA-DRIVEr™ platform to target previously untreatable common cancers with small molecules and biologics.